Makoto Kawashima

2PUBLICATIONS
2CO-AUTHORS
Neurology and neuromuscular diseasesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 13, 2023
Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg nemolizumab subcutaneously every 4 weeks: subgroup analysis from a phase 3, randomized, controlled trial.

Kenji Kabashima, Takayo Matsumura, Yoshiteru Hayakawa

|Nov 10, 2022
A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis.

Makoto Kawashima, Daisuke Watanabe, Kosuke Fujio

Pageof 1

Frequent Collaborators

1 joint publications

Kenji Kabashima

1 joint publications

Takayo Matsumura